New research suggests that Ambry Genetics’ RNA analysis can improve the accuracy of exome testing. The study, published in Genetics in Medicine, showed that targeted RNA analysis using Ambry’s ExomeReveal test can help “resolve uncertain findings and improve diagnostic clarity,” according to the company. Aliso Viejo-based Ambry, Orange County’s third-largest medical diagnostics and testing company by local headcount, was acquired by Chicago-base…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.